Kenneth Hughes
Geschäftsführer bei MICROBIX BIOSYSTEMS INC.
Vermögen: 106 015 $ am 31.05.2024
Aktive Positionen von Kenneth Hughes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Geschäftsführer | 03.06.2019 | - |
| Roker Biotechnologies, Inc. | Gründer | 01.01.2010 | - |
| Präsident | 01.01.2010 | - |
Karriereverlauf von Kenneth Hughes
Ehemalige bekannte Positionen von Kenneth Hughes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Itp Biomedica Corp. | Vorstandsvorsitzender | 01.01.2014 | 01.01.2019 |
| Präsident | 01.01.2014 | 01.01.2019 | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | 01.01.2013 |
| MICROBIX BIOSYSTEMS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 | 01.01.2010 |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Gründer | 01.01.2008 | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
Ausbildung von Kenneth Hughes
| The University of Sheffield | Undergraduate Degree |
| University of London | Doctorate Degree |
Statistik
International
| Kanada | 7 |
| Vereinigtes Königreich | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| President | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
| Itp Biomedica Corp. | |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Health Technology |
| Roker Biotechnologies, Inc. |
- Börse
- Insiders
- Kenneth Hughes
- Erfahrung
